SCHEMBL9513071

SCHEMBL9513071

CCC(=O)c1cnc2ccc(OCCO)cc2c1Nc1ccc(F)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9514746 0.94 — —
SCHEMBL9513396 0.88 — —
SCHEMBL9515652 0.88 TP53 (0.50) —
SCHEMBL9516804 0.85 — —
SCHEMBL9350578 0.83 — —
SCHEMBL9160371 0.81 — —
SCHEMBL7180952 0.81 ATP4A (0.56) —
SCHEMBL9515609 0.78 — —
SCHEMBL5930028 0.78 CSF1R (0.63) —
SCHEMBL9508799 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0330485-B1 4-AMINO-3-ACYL QUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF GASTRIC ACID SECRETION SmithKline Beecham Intercredit B.V. (NL) 1993-05-26 — — EP claimed
Send feedback